Top Markets
Coin of the day
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
Ранг среди акций #32096
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Цена акции
$0.21483059
Последняя синхронизация: 2024-05-07
Рыночная капитализация
$11.13M
Изменение (1 день)
0.34%
Изменение (1 год)
0.00%
Страна
CA
Торговля Antibe Therapeutics Inc. (ATE)

Категория

История дроблений акций Antibe Therapeutics Inc. (ATE)
Акции Antibe Therapeutics Inc. (символ: ATE) прошли через 0 дроблений.
Последнее дробление произошло Aug 18, 2026.
Одна акция ATE, купленная до Aug 18, 2026, сейчас соответствует 0 акциям ATE.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
3 x12
US